Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery（STP-LRG-1）

October 15, 2022 updated by: Chang-Ming Huang, Prof., Fujian Medical University

Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery: a Survey Based on Follow-up Questionnaire

To prospectively evaluate the effect of the gastric cancer specialist training program of Fujian Medical University Union Hospital on laparoscopic gastric cancer surgery.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Laparoscopic gastric cancer surgery has the advantages of less trauma, quick postoperative recovery, less postoperative pain symptoms, less postoperative complications, and shorter average hospital stay. In addition, the surgical safety and oncological efficacy of laparoscopic radical gastrectomy for gastric cancer have been obtained. Confirmed by numerous clinical studies.

However, due to the difficult operation, complex anatomy and high technical requirements of laparoscopic gastric cancer surgery, the operator needs to have rich experience in laparotomy, skilled laparoscopic operation skills, and the ability to actively prevent and deal with complications after surgery. Therefore, at this stage, laparoscopic radical gastrectomy for gastric cancer is only suitable for large hospitals with certain conditions, and it should be gradually carried out on the basis of chief surgeons with rich clinical experience in radical gastrectomy and skilled laparoscopic technical experience.

The gastric cancer specialist training program (STP-LRG-1) of Fujian Medical University Affiliated Union Hospital (STP-LRG-1) has more than 9 years of trainee training experience. The effectiveness of STP-LRG-1 has not been prospectively evaluated, so this study aimed to prospectively evaluate whether STP-LRG-1 can improve the surgical skills of trainees and ultimately improve short-term outcomes for patients during and after surgery

Study Type

Observational

Enrollment (Actual)

183

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Fujian
      • Fuzhou, Fujian, China, 350000
        • Fujian Medical University Union Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants were gastric cancer specialists who trained in the Department of Gastric Surgery of FJMU-UH from 2013 to 2020

Description

Inclusion Criteria:

  1. The title of fellow physician or above, with experience in performing laparoscopic radical gastrectomy for gastric cancer independently or under supervision;
  2. The hardware facilities and staffing of the operating room support the completion of laparoscopic gastric cancer surgery;
  3. Surgical videos of laparoscopic radical gastrectomy before and after the training required for this study can be provided;
  4. Clinicopathological data, intraoperative and postoperative short-term outcome data of the patients operated by the surgeon before and after training can be provided;
  5. Informed consent

Exclusion Criteria:

  1. Refuse to carry out laparoscopic gastric cancer surgery;
  2. Due to the limitations of equipment or policies, the unit cannot routinely carry out laparoscopic gastric cancer surgery;
  3. Those who have not performed laparoscopic gastric cancer surgery within 1 month before participating in the training and cannot provide video;
  4. Those who are not expected to perform laparoscopic gastric cancer surgery within 1 month after participating in the training;
  5. Participate in other clinical investigators during the same period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
gastric cancer specialist training program
Procedure: gastric cancer specialist training program
The gastric cancer specialist training program includes technical training and non-technical training. The technical training includes 1. The whole process of laparoscopic gastric cancer surgery technical teaching 2. Operation practice 3. Operation video review, non-technical training includes 1. Difficult case discussion 2. Specialists Session 3. Lymph node sorting training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient complication rate
Time Frame: one year
Rate of reduction in surgical patient complications after trainee training
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fujian Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 11, 2021

Primary Completion (Actual)

December 10, 2021

Study Completion (Actual)

December 25, 2021

Study Registration Dates

First Submitted

February 22, 2022

First Submitted That Met QC Criteria

October 15, 2022

First Posted (Actual)

October 18, 2022

Study Record Updates

Last Update Posted (Actual)

October 18, 2022

Last Update Submitted That Met QC Criteria

October 15, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FUGES-026

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastric Cancer

Clinical Trials on gastric cancer specialist training program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe